SEATTLE, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of two oral presentations at the upcoming European Society of Gene ...
Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced that it will host a conference call and live webcast at 8:30 am ET ...
Tekton Research, a leading multi-site clinical trial company, is proud to announce the addition of three new sites, five new Principal Investigators (PIs), and a renowned CNS Consultant to its ...
BENTONVILLE, Ark., Sept. 26, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced that its Chief Executive Officer and Chief Financial Officer has resigned, effective September 30 ...
Cannabis Evaluations to Connecticut, Now Operating in 19 States Nationwide. Mesquite, NV — September 26, 2025 — Dogecoin Cash, Inc. (OTCQB: DOGP today announced that its subsi ...
The webcast presentation will take place at 1:15 p.m. ET on Tuesday, September 30, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/fall2025/ or ...
CARSON CITY, Nev., Sept. 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and ...
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System. INBS anticipates FDA 510(k) clearance in the second half of 2026.
The Gala will feature moving patient stories, captivating artistic performances, commemorative videos, gourmet dining, and inspiring encounters with current and former patients— all in celebration of ...
ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba® is the subject of an exclusive, transferable license to use the ...
New Clue Survey Reveals Misinformation About Reproductive Health is a Top Concern for American Women
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- New data released today reveals medical misinformation about reproductive health is a major concern for 82% of U.S. women* with more than 1 in 2 saying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback